Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
Chenxi Du, Lei Wang, Qianwen Guan, Hongyu Yang, Tingkai Chen, Yijun Liu, Qihang Li, Weiping Lyu, Xin Lu, Ying Chen, Yang Liu, Hui Liu, Feng Feng, Wenyuan Liu, Zongliang Liu, Wei Li, Yao Chen & Haopeng Sun. (2022)
N
-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer’s Disease
. Journal of Medicinal Chemistry 65:16, pages 11365-11387.
Crossref
Crossref
Jose Enrique de la Rubia Ortí, Jose Luis Platero, Iván Hu Yang, Jose Joaquin Ceron, Asta Tvarijonaviciute, Pablo Selvi Sabater, María Benlloch, David Sancho-Cantus & Sandra Sancho. (2021) Possible Role of Butyrylcholinesterase in Fat Loss and Decreases in Inflammatory Levels in Patients with Multiple Sclerosis after Treatment with Epigallocatechin Gallate and Coconut Oil: A Pilot Study. Nutrients 13:9, pages 3230.
Crossref
Crossref
Israel Silman. (2021) The multiple biological roles of the cholinesterases. Progress in Biophysics and Molecular Biology 162, pages 41-56.
Crossref
Crossref
Weiwei Liu, Yan Cao, Yue Lin, Keai Sinn Tan, Haishan Zhao, Haihua Guo & Wen Tan. (2021) Enhancement of Fear Extinction Memory and Resistance to Age-Related Cognitive Decline in Butyrylcholinesterase Knockout Mice and (R)-Bambuterol Treated Mice. Biology 10:5, pages 404.
Crossref
Crossref
Shuaishuai Xing, Qi Li, Baichen Xiong, Yao Chen, Feng Feng, Wenyuan Liu & Haopeng Sun. (2020) Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism. Medicinal Research Reviews 41:2, pages 858-901.
Crossref
Crossref
Shuaishuai Xing, Ying Chen, Baichen Xiong, Weixuan Lu, Qi Li, Yuanyuan Wang, Mengxia Jiao, Feng Feng, Yao Chen, Wenyuan Liu & Haopeng Sun. (2021) Synthesis and bio-evaluation of a novel selective butyrylcholinesterase inhibitor discovered through structure-based virtual screening. International Journal of Biological Macromolecules 166, pages 1352-1364.
Crossref
Crossref
Vedran Milankovic & Tamara Lazarevic-Pasti. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
625
660
.
Iris Betzaida Molina-Pintor, Aurora Elizabeth Rojas-García, Yael Yvette Bernal-Hernández, Irma Martha Medina-Díaz, Cyndia Azucena González-Arias & Briscia Socorro Barrón-Vivanco. (2020) Relationship between butyrylcholinesterase activity and lipid parameters in workers occupationally exposed to pesticides. Environmental Science and Pollution Research 27:31, pages 39365-39374.
Crossref
Crossref
Yan Gu, Mathilda Jing Chow, Anil Kapoor, Wenjuan Mei, Yanzhi Jiang, Judy Yan, Jason De Melo, Maryam Seliman, Huixiang Yang, Jean-Claude Cutz, Michael Bonert, Pierre Major & Damu Tang. (2018) Biphasic Alteration of Butyrylcholinesterase (BChE) During Prostate Cancer Development. Translational Oncology 11:4, pages 1012-1022.
Crossref
Crossref
Carey N. Pope & Stephen Brimijoin. (2018) Cholinesterases and the fine line between poison and remedy. Biochemical Pharmacology 153, pages 205-216.
Crossref
Crossref
Carey Pope, Kirstin Hester & Lester Sultatos. 2018.
Nady Braidy, Anne Poljak, Tharusha Jayasena & Perminder Sachdev. 2017. Natural Products Targeting Clinically Relevant Enzymes. Natural Products Targeting Clinically Relevant Enzymes
297
318
.
Iris Mangas, Zoran Radić, Palmer Taylor, Majid Ghassemian, Héctor Candela, Eugenio Vilanova & Jorge Estévez. (2016) Butyrylcholinesterase identification in a phenylvalerate esterase-enriched fraction sensitive to low mipafox concentrations in chicken brain. Archives of Toxicology 91:2, pages 909-919.
Crossref
Crossref
Zhi-Min Wang, Pei Cai, Qiao-Hong Liu, Ding-Qiao Xu, Xue-Lian Yang, Jia-Jia Wu, Ling-Yi Kong & Xiao-Bing Wang. (2016) Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 123, pages 282-297.
Crossref
Crossref
Stephen Brimijoin, Vicky Ping Chen, Yuan-Ping Pang, Liyi Geng & Yang Gao. (2016) Physiological roles for butyrylcholinesterase: A BChE-ghrelin axis. Chemico-Biological Interactions 259, pages 271-275.
Crossref
Crossref
Yu-Fang ShenGan-Hong ChenShu-Hsien LinGialih Lin. (2016)
Molecular modeling and docking calculations of 4-acyloxy-biphenyl-4′-
N
-butylcarbamates as potential inhibitors of human butyrylcholinesterase
. Canadian Journal of Chemistry 94:1, pages 72-77.
Crossref
Crossref
Sigurd Hartnett, Hongbo Gao, Sabrina Schnack & Yifan Li. (2015) Reduced vagal control of the heart in high-fat diet mice: a potential role of increased butyrylcholinesterase. Physiological Reports 3:11, pages e12609.
Crossref
Crossref
Ozden Tacal & Lawrence M. Schopfer. (2014) Healthy F-16 pilots show no evidence of exposure to tri-ortho-cresyl phosphate through the on-board oxygen generating system. Chemico-Biological Interactions 215, pages 69-74.
Crossref
Crossref
Miroslav Pohanka & Lucie Drtinova. (2013) Spectrophotometric methods based on 2,6-dichloroindophenol acetate and indoxylacetate for butyrylcholinesterase activity assay in plasma. Talanta 106, pages 281-285.
Crossref
Crossref
Roger M. Lane & Yunsheng He. (2012) Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype. Alzheimer's & Dementia 9:2.
Crossref
Crossref
Glynis Johnson & Samuel W. Moore. (2012) Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene. Neurochemistry International 61:5, pages 783-797.
Crossref
Crossref
Nigel Hoggard, Morven Cruickshank, Kim‐Marie Moar, Shabina Bashir & Claus‐Dieter Mayer. (2012) Using Gene Expression to Predict Differences in the Secretome of Human Omental vs. Subcutaneous Adipose Tissue. Obesity 20:6, pages 1158-1167.
Crossref
Crossref
Vita Dolžan. 2012. Pharmacogenetics and Individualized Therapy. Pharmacogenetics and Individualized Therapy
13
80
.
Gumpeny Ramachandra Sridhar, Talluri Sekhar, Padmanabhuni Venkata Nageswara Rao & Allam Appa Rao. (2012) Human butyrylcholinesterase knock-out equivalent: Potential to assess role in Alzheimer’s disease. Advances in Alzheimer's Disease 01:01, pages 1-11.
Crossref
Crossref
Miroslav Pohanka. (2011) CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY. Biomedical Papers 155:3, pages 219-223.
Crossref
Crossref
Ebru Bodur & Paul G. Layer. (2011) Counter-regulation of cholinesterases: Differential activation of PKC and ERK signaling in retinal cells through BChE knockdown. Biochimie 93:3, pages 469-476.
Crossref
Crossref
Gumpeny R. Sridhar, Allam Appa Rao, Kudipudi Srinivas, Gumpeny Nirmala, Gumpeny Lakshmi, Dasika Suryanarayna, Padmanabhuni V. Nageswara Rao, Dowluru G.S.V.G.L. Kaladhar, Sali Veeresh Kumar, Tatavarthi Uma Devi, Turaga Nitesh & Thota Hanuman. (2010) Butyrylcholinesterase in metabolic syndrome. Medical Hypotheses 75:6, pages 648-651.
Crossref
Crossref
Einor Ben Assayag, Shani Shenhar-Tsarfaty, Keren Ofek, Lilach Soreq, Irena Bova, Ludmila Shopin, Ronan M. G. Berg, Shlomo Berliner, Itzhak Shapira, Natan M. Bornstein & Hermona Soreq. (2010) Serum Cholinesterase Activities Distinguish between Stroke Patients and Controls and Predict 12-Month Mortality. Molecular Medicine 16:7-8, pages 278-286.
Crossref
Crossref
Gracielle Alves-Amaral, Marcelo Pires-Oliveira, Ana Luiza Andrade-Lopes, Tiago Chiavegatti & Rosely Oliveira Godinho. (2010) Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: Effects of sex hormone withdrawal. Chemico-Biological Interactions 186:1, pages 9-15.
Crossref
Crossref
I.M.S. Sales, R.L.M. Freitas, G.B. Saldanha, G.F. Souza & R.M. Freitas. (2010) Choline acetyltransferase and acetylcholinesterase activities are reduced in rat striatum and frontal cortex after pilocarpine-induced seizures. Neuroscience Letters 469:1, pages 81-83.
Crossref
Crossref